Ren-Hua Guo (Renhua Guo)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Topics

Myasthenia Gravis

Sentinel Lymph Node

Epidermal Growth Factor Receptor

Top Venues

Thoracic cancer

Oxidative medicine and cellular longevity

Journal of cellular and molecular medicine

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jin-Ji Yang, Yan Zhang, Lin Wu, Jie Hu, Zhe-Hai Wang, Jing-Hua Chen, Yun Fan, Gen Lin, Qi-Ming Wang, Yu Yao, Jun Zhao, Yuan Chen, Jian Fang, Yong Song, Wei Zhang, Ying Cheng, Ren-Hua Guo, Xing-Ya Li, He-Peng Shi, Wei-Zhe Xue, Di Han, Pei-Long Zhang, Yi-Long Wu
Vebreltinib for Advanced Non-Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Huaying Wang, Li-E Lin, Chuqiao Liang, Jiaohui Pang, Jiani C Yin, Junli Zhang, Yang Shao, Chengming Sun, Ren-Hua Guo
Landscape of Concomitant Driver Alterations in Classical EGFR -Mutated Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Jun Shao, Yunru Gu, Ren-Hua Guo, Jiali Xu
A Visual Analysis of the Research Dynamics in Resistance to EGFR Inhibitors for NSCLC. Drug design, development and therapy 18 (2024)
Jun Shao, Yunru Gu, Ren-Hua Guo, Jiali Xu
A Visual Analysis of the Research Dynamics in Resistance to EGFR Inhibitors for NSCLC. Drug design, development and therapy 18 (2024)
Chen Zhang, Xiyi Lu, Xinyin Liu, Jiali Xu, Jun Li, Tianyu Qu, Jiali Dai, Ren-Hua Guo
Carbonic Anhydrase IX Controls Vulnerability to Ferroptosis in Gefitinib-Resistant Lung Cancer. Oxidative medicine and cellular longevity 2023 (2023)
Jiali Dai, Xinyin Liu, Jun Li, Tianyu Qu, Yanan Cui, Shidai Jin, Erbao Zhang, Ren-Hua Guo
Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR-TKIs in advanced non-small cell lung cancer: A systematic review and network meta-analysis. Thoracic cancer (2023)
Jiali Dai, Xinyin Liu, Jun Li, Tianyu Qu, Yanan Cui, Shidai Jin, Erbao Zhang, Ren-Hua Guo
Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR-TKIs in advanced non-small cell lung cancer: A systematic review and network meta-analysis. Thoracic cancer 14 (6) (2023)
Jiali Dai, Xinyin Liu, Jun Li, Tianyu Qu, Yanan Cui, Shidai Jin, Erbao Zhang, Ren-Hua Guo
Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR-TKIs in advanced non-small cell lung cancer: A systematic review and network meta-analysis. Thoracic cancer 14 (6) (2023)
Chen Zhang, Xiyi Lu, Xinyin Liu, Jiali Xu, Jun Li, Tianyu Qu, Jiali Dai, Ren-Hua Guo
Carbonic Anhydrase IX Controls Vulnerability to Ferroptosis in Gefitinib-Resistant Lung Cancer. Oxidative medicine and cellular longevity 2023 (2023)
Yun Chen, Chen Zhang, Shidai Jin, Jun Li, Jiali Dai, Zhihong Zhang, Ren-Hua Guo
Pemetrexed induces ROS generation and cellular senescence by attenuating TS-mediated thymidylate metabolism to reverse gefitinib resistance in NSCLC. Journal of cellular and molecular medicine (2023)
Chen Zhang, Xiyi Lu, Xinyin Liu, Jiali Xu, Jun Li, Tianyu Qu, Jiali Dai, Ren-Hua Guo
Carbonic Anhydrase IX Controls Vulnerability to Ferroptosis in Gefitinib-Resistant Lung Cancer. Oxidative medicine and cellular longevity 2023 (2023)
Yanan Cui, Jun Li, Pengpeng Zhang, Dandan Yin, Ziyu Wang, Jiali Dai, Wei Wang, Erbao Zhang, Ren-Hua Guo
B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Jiali Dai, Xinyin Liu, Jun Li, Tianyu Qu, Yanan Cui, Shidai Jin, Erbao Zhang, Ren-Hua Guo
Efficacy and safety of antiangiogenic agents or chemotherapy plus EGFR-TKIs in advanced non-small cell lung cancer: A systematic review and network meta-analysis. Thoracic cancer 14 (6) (2023)
Chen Zhang, Xinyin Liu, Shidai Jin, Yi Chen, Ren-Hua Guo
Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Molecular cancer 21 (1) (2022)
Wen Gao, Lingxiang Wu, Shidai Jin, Jun Li, Xinyin Liu, Jiali Xu, Wei Zhang, Qixing Gong, Chunxiao Sun, Wei Wang, Zidun Wang, Yang W Shao, Jiani C Yin, Lu Shen, Liang Chen, Qianghu Wang, Ren-Hua Guo
Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis. Journal for immunotherapy of cancer 10 (11) (2022)
Qingqing Zhu, Chongguo Zhang, Tianyu Qu, Xiyi Lu, Xuezhi He, Wei Li, Dandan Yin, Liang Han, Ren-Hua Guo, Erbao Zhang
MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc-Mediated Cell-Cycle Progression and Proliferation in Lung Cancer. Cancer research 82 (23) (2022)
Xiao Liang, Wei Zhang, Jun Li, Jing Zhu, Jun Shao, Jing Wang, Hongshuai Wu, Jiali Dai, Jun Li, Jiali Xu, Wei Wang, Ren-Hua Guo
Clinical implications of ctDNA for EGFR-TKIs as first-line treatment in NSCLC. Journal of cancer research and clinical oncology (2022)
Fangyan Gao, Qianqian Wang, Chang Zhang, Chen Zhang, Tianyu Qu, Jingya Zhang, Ji-Fu Wei, Ren-Hua Guo
RNA methyltransferase METTL3 induces intrinsic resistance to gefitinib by combining with MET to regulate PI3K/AKT pathway in lung adenocarcinoma. Journal of cellular and molecular medicine 25 (5) (2021)
Caicun Zhou, Yina Wang, Jun Zhao, Gongyan Chen, Zhihua Liu, Kangsheng Gu, Meijuan Huang, Jianxing He, Jianhua Chen, Zhiyong Ma, Jifeng Feng, Jianhua Shi, Xinmin Yu, Ying Cheng, Yu Yao, Yuan Chen, Ren-Hua Guo, Xiaoyan Lin, Zhehai Wang, Guanghui Gao, Quanren Wang, Weixia Li, Xinfeng Yang, Lihong Wu, Jun Zhang, Shengxiang Ren
Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (5) (2020)